Skip to content

Electro-acupuncture for insomnia in patients with lung cancer: a randomized controlled trial

Electro-acupuncture for insomnia in patients with lung cancer: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026395
Enrollment
Unknown
Registered
2019-10-08
Start date
2019-12-25
Completion date
Unknown
Last updated
2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer-related insomnia

Interventions

1:electro-acupuncture
2:sham electro-acupuncture

Sponsors

Shanghai Municipal Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Continuous insomnia related to lung cancer treatment or cancer itself for at least 3 months, and meets the diagnostic criteria of chronic insomnia according to The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V), American Psychiatric Association (APA); (2) Diagnosed with stage I-IIIA pulmonary malignancy according to imaging result, histologic examination and TNM classification; (3) An Eastern Cooperation Oncology Group (ECOG) performance status of less than 2; (4) Score of Pittsburgh Sleep Quality Index (PSQI) of more than 11; (5) Male or female patients aged between 19 to 70 years old; (6) Have never received acupuncture treatment; (7) Willing to participate in the trial and provide written consent.

Exclusion criteria

Exclusion criteria: (1) A plan for surgery and chemotherapy during the trial; (2) A diagnosis of secondary insomnia caused by depression, anxiety or other psychiatric disorders and addition of caffeine, alcohol or drugs; (3) Index of cancer pain measured by the numeric rating scale >= 4; (4) A diagnosis of severe cognitive deficit failing to cooperate; (5) A diagnosis of severe diseases of the cardiovascular, hepatic, renal, cerebrovascular, or hematopoietic systems; (6) Acupuncture area with skin infection, ulcer and soars; (7) Pregnant or breastfeeding women; (8) Having participated in other clinic trials within 4 weeks of the beginning of this trial.

Design outcomes

Primary

MeasureTime frame
Pittsburgh sleep quality index (PSQI);

Secondary

MeasureTime frame
wActiSleep-BT wireless sleep monitor;Quality of Life Questionnaire Core-30;Patient Health Questionnaire-9;

Countries

China

Contacts

Public ContactXu Shifen

Shanghai Municipal Hospital of Traditional Chinese Medicine

xu_teacher2006@126.com+86 13761931393

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 17, 2026